Annual EBITDA
$21.48B$1.34B+6.65%
Summary
- Current Value
- As of today, NVS annual EBITDA is $21.48B, up +6.65% on
- Historical Performance
- NVS annual EBITDA is up +26.15% over the past 3 years, and up +34.97% over the past 5 years
- All-Time High Comparison
- NVS annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- NVS annual EBITDA is +25.85% above its 3-year low of $17.07B reached on an earlier date
- Sector Comparison
- NVS annual EBITDA is higher than 99.66% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $21.48B | +6.7% | +26.1% | +35.0% | +92.5% | |
| Quarterly EBITDA | $5.45B | -9.6% | +34.5% | +16.0% | +45.1% | |
| TTM EBITDA | $22.49B | +10.1% | +26.0% | +34.8% | +54.1% | |
| Price | $142.81 | +42.5% | +58.8% | +51.9% | +179.4% | |
| PE Ratio | 19.47 | +13.9% | -31.4% | -27.2% | +63.3% | |
| Annual Revenue | $50.29B | +10.7% | -2.6% | +5.9% | +14.0% | |
| Annual EPS | $5.86 | -17.4% | -44.8% | +93.2% | +59.3% | |
| Annual EBIT | $15.42B | +29.9% | +32.9% | +52.8% | +73.2% | |
| Annual Net Income | $11.93B | +39.2% | -50.3% | +67.0% | +41.7% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $21.48B | at high | |
| 5Y | $21.48B | at high | |
| All | $21.48B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $17.07B | N/A | +25.9% |
| 5Y | $15.93B | N/A | +34.9% |
| All | $4.15B | +417.3% |
EBITDA History
FAQ
What is the current annual EBITDA of NVS?
As of today, NVS annual EBITDA is $21.48B
What is 1-year change in NVS annual EBITDA?
NVS annual EBITDA is up +6.65% year-over-year
What is 3-year change in NVS annual EBITDA?
NVS annual EBITDA is up +26.15% over the past 3 years
How far is NVS annual EBITDA from its all-time high?
NVS annual EBITDA is currently at its all-time high
How does NVS annual EBITDA rank versus sector peers?
NVS annual EBITDA is higher than 99.66% of companies in Healthcare sector
When is NVS next annual earnings release?
The next annual earnings release for NVS is on
Quarterly EBITDA
$5.45B$479.73M-8.09%
Summary
- Current Value
- As of today, NVS quarterly EBITDA is $5.45B, down -8.09% on
- Historical Performance
- NVS quarterly EBITDA is down -9.62% year-over-year, and up +34.45% over the past 3 years
- All-Time High Comparison
- NVS quarterly EBITDA is currently -16.33% below its historical high of $6.52B set on
- 3-Year Low Comparison
- NVS quarterly EBITDA is +25.07% above its 3-year low of $4.36B reached on
- Sector Comparison
- NVS quarterly EBITDA is higher than 99.55% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $5.45B | -8.1% | -9.6% | +34.5% | +16.0% | |
| Annual EBITDA | $21.48B | – | +6.7% | +26.1% | +35.0% | |
| TTM EBITDA | $22.49B | -2.5% | +10.1% | +26.0% | +34.8% | |
| Price | $142.81 | +9.0% | +42.5% | +58.8% | +51.9% | |
| PE Ratio | 19.47 | +8.9% | +13.9% | -31.4% | -27.2% | |
| Quarterly Revenue | $13.88B | -2.8% | +8.2% | +32.3% | +13.2% | |
| Quarterly EPS | $2.02 | -3.6% | +28.4% | +179.9% | +140.3% | |
| Quarterly EBIT | $4.20B | -11.7% | +3.2% | +96.1% | +41.5% | |
| Quarterly Net Income | $3.92B | -4.1% | +23.1% | +194.8% | +102.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.93B | -8.1% | |
| 3Y | $6.52B | -16.3% | |
| 5Y | $6.52B | -16.3% | |
| All | $6.52B | -16.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $5.37B | N/A | +1.5% |
| 3Y | $4.36B | +25.1% | |
| 5Y | $3.92B | N/A | +38.9% |
| All | -$10.99B | +149.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of NVS?
As of today, NVS quarterly EBITDA is $5.45B
What is NVS quarterly EBITDA most recent change?
NVS quarterly EBITDA was down -8.09% on September 29, 2025
What is 1-year change in NVS quarterly EBITDA?
NVS quarterly EBITDA is down -9.62% year-over-year
How far is NVS quarterly EBITDA from its all-time high?
NVS quarterly EBITDA is currently -16.33% below its historical high of $6.52B set on September 30, 2023
How does NVS quarterly EBITDA rank versus sector peers?
NVS quarterly EBITDA is higher than 99.55% of companies in Healthcare sector
When is NVS next earnings release?
The next earnings release for NVS is on
TTM EBITDA
$22.49B$579.98M-2.51%
Summary
- Current Value
- As of today, NVS TTM EBITDA is $22.49B, down -2.51% on
- Historical Performance
- NVS TTM EBITDA is up +10.10% year-over-year, and up +25.98% over the past 3 years
- All-Time High Comparison
- NVS TTM EBITDA is currently -2.51% below its historical high of $23.07B set on
- 3-Year Low Comparison
- NVS TTM EBITDA is +21.18% above its 3-year low of $18.56B reached on
- Sector Comparison
- NVS TTM EBITDA is higher than 99.37% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $22.49B | -2.5% | +10.1% | +26.0% | +34.8% | |
| Annual EBITDA | $21.48B | – | +6.7% | +26.1% | +35.0% | |
| Quarterly EBITDA | $5.45B | -8.1% | -9.6% | +34.5% | +16.0% | |
| Price | $142.81 | +9.0% | +42.5% | +58.8% | +51.9% | |
| PE Ratio | 19.47 | +8.9% | +13.9% | -31.4% | -27.2% | |
| TTM Revenue | $54.45B | +2.0% | +12.1% | +11.0% | +12.8% | |
| TTM EPS | $7.33 | +6.5% | -14.5% | -24.6% | +137.2% | |
| TTM EBIT | $17.29B | +0.8% | +20.1% | +54.2% | +74.6% | |
| TTM Net Income | $14.42B | +5.4% | +22.6% | -33.1% | +103.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $23.07B | -2.5% | |
| 3Y | $23.07B | -2.5% | |
| 5Y | $23.07B | -2.5% | |
| All | $23.07B | -2.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $21.44B | N/A | +4.9% |
| 3Y | $18.56B | +21.2% | |
| 5Y | $16.92B | +32.9% | |
| All | -$1.50B | +1598.2% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of NVS?
As of today, NVS TTM EBITDA is $22.49B
What is NVS TTM EBITDA most recent change?
NVS TTM EBITDA was down -2.51% on September 29, 2025
What is 1-year change in NVS TTM EBITDA?
NVS TTM EBITDA is up +10.10% year-over-year
How far is NVS TTM EBITDA from its all-time high?
NVS TTM EBITDA is currently -2.51% below its historical high of $23.07B set on June 30, 2025
How does NVS TTM EBITDA rank versus sector peers?
NVS TTM EBITDA is higher than 99.37% of companies in Healthcare sector
When is NVS next earnings release?
The next earnings release for NVS is on
EBITDA Formula
Data Sources & References
- NVS Official Website www.novartis.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1114448/000111444825000003/0001114448-25-000003-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm
- NVS Profile on Yahoo Finance finance.yahoo.com/quote/NVS
- NVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvs